Overview

Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of roprostin in the treatment of refractory AA after radiotherapy.
Phase:
PHASE4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
romiplostim